Selective Laser Trabeculoplasty, or SLT, is a form of laser surgery that is used to lower intraocular pressure in glaucoma. Patients who have open-angle glaucoma and are in need of lowering of their intraocular pressure are eligible for the procedure. SLT lowers the IOP by about 30% when used as initial therapy. The effect will generally last between 1-5 years, and in rare cases, longer than that.
Candidates for this procedure are patients with open-angle glaucoma (when the drainage system in the front part of the eye is open) and require the lowering of their intraocular pressure (IOP). A laser is applied to the drainage tissue located in the eye, and helps with drainage of the fluid through the drain and out of the eye. Results may take up to 3 months.
A risk associated with SLT is post-operative inflammation, which is generally mild and treated with eye drops or non-steroidal anti-inflammatory drug. Swagel Wootton Hiatt has been performing Glaucoma SLT with the latest equipment and our doctors have went through extensive training to provide you with the best treatment available today. The effects can last years in most cases.
Some patients will only need laser treatment, while others will still require additional IOP lowering and may have to take glaucoma medication as well. SLT is not considered a cure for glaucoma, but as a treatment to lower the IOP if necessary.